Russell L. Allen
Keine laufenden Positionen mehr
Profil
Russell L.
Allen formerly worked at IBEX Technologies, Inc., as Director, Ligand Pharmaceuticals, Inc., as VP-Corporate Development & Strategic Planning in 2001, Sanofi Winthrop, as Vice President in 1996, Gilead Connecticut, Inc., as Senior Vice President-Corporate Development in 2004, and Ceragenix Pharmaceuticals, Inc., as Vice President-Corporate Development.
Mr. Allen received his undergraduate degree from Amherst College and Masters Business Admin degree from Harvard Graduate School of Education.
Ehemalige bekannte Positionen von Russell L. Allen
| Unternehmen | Position | Ende |
|---|---|---|
Gilead Connecticut, Inc.
 Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Corporate Officer/Principal | 01.01.2004 |
| LIGAND PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01.01.2001 |
Sanofi Winthrop
 Sanofi Winthrop Pharmaceuticals: OtherHealth Technology Part of Sanofi, Sanofi Winthrop is a French company that specializes in medicinal chemicals and botanical products. The company is based in Paris, France. | Corporate Officer/Principal | 01.01.1996 |
| IBEX TECHNOLOGIES | Direktor/Vorstandsmitglied | - |
Ceragenix Pharmaceuticals, Inc.
 Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | Corporate Officer/Principal | - |
Ausbildung von Russell L. Allen
| Amherst College | Undergraduate Degree |
| Harvard Graduate School of Education | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Ceragenix Pharmaceuticals, Inc.
Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | Health Technology |
IBEX Technologies, Inc.
 IBEX Technologies, Inc. Medical SpecialtiesHealth Technology IBEX Technologies, Inc. manufactures and markets enzymes for biomedical use. The firm also specializes in the custom aliquoting, filling, and lyophilization of enzymes in diagnostic disposables for medical devices. Its products include glycobiology enzymes from flavobacterium heparinum, collagen assays, collagen antibodies, and diamine oxidase liquid. The company was founded by Robert A. Heft on April 10, 1972 and is headquartered in Montréal, Canada. | Health Technology |
Gilead Connecticut, Inc.
Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Health Technology |
Sanofi Winthrop
Sanofi Winthrop Pharmaceuticals: OtherHealth Technology Part of Sanofi, Sanofi Winthrop is a French company that specializes in medicinal chemicals and botanical products. The company is based in Paris, France. | Health Technology |
